Mitral Valve (Repair & Replacement)Monday, October 19, 2026
Tissue Mitral Valve Replacements Market Forecast to 2035, Driven by Aging Population and Transcatheter Innovation - IndexBox
1 min read·By E. Nolan Beckett, MD·Source: IndexBox
From The Valve Wire
A market research firm projects growth in tissue mitral valve replacement through 2035, attributing it to population aging and transcatheter innovation.
That is the entire substance of the release.
Treat these forecasts as what they are: extrapolations from demographic curves and current procedure volumes, sold to investors, with no clinical input and no sensitivity analysis for the thing that actually determines mitral volumes.
Which is reimbursement and evidence.
Source Abstract
Tissue Mitral Valve Replacements Market Forecast to 2035, Driven by Aging Population and Transcatheter Innovation IndexBox
Read the Original
Full article at IndexBox
Open at IndexBox →The Valve Wire summarizes; we link out to primary sources for verification.
More in Mitral Valve (Repair & Replacement)
- Mitral Valve (Repair & Replacement)· Annali italiani di chirurgiaMultidimensional Echocardiographic Parameters Predict Left Ventricular Functional Recovery After Coronary Artery Bypass Grafting.
- Mitral Valve (Repair & Replacement)· Medical Product OutsourcingFDA Flags Edwards TMVR Delivery System After Fatality - Medical Product Outsourcing
- Mitral Valve (Repair & Replacement)· Medical DailyFour Lots of Edwards Mitral Valve Delivery Systems Pulled After Balloon Bursts Linked to One Patient Death - Medical Daily
Elsewhere in Today’s Issue
- Aortic Valve (TAVR/TAVI)· Acta cardiologicaIntravascular imaging improves outcomes in left main PCI: insights from acute and chronic presentations.
- Aortic Valve (TAVR/TAVI)· Journal of nursing managementDevelopment and Initial Psychometric Validation of a Nurse-Assessed Discharge Readiness Scale for Patients With Coronary Heart Disease Following Percutaneous Coronary Intervention.
- Aortic Valve (TAVR/TAVI)· CureusUnmasking Brugada Syndrome With Oral Propafenone in a Resource-Limited Setting: A Case Report.